Optimizing Patient-Centric Clinical Outcome Assessments for Use in Parkinson's Disease Clinical Trials: Critical Path for Parkinson's Multistakeholder Initiative

被引：0

作者：

Speck, R. ^{[1
]}

Trundell, D. ^{[2
]}

Cedarbaum, J. M. ^{[3
]}

Campbell, M. ^{[4
]}

Chin, P. S. ^{[5
]}

Crawford, S. ^{[6
]}

Dam, T. ^{[7
]}

Dexter, D. T. ^{[8
]}

Goldfine, A. M. ^{[9
]}

Klapper, K. ^{[1
]}

Kopil, C. M. ^{[10
]}

Lee, S. J. ^{[11
]}

Marek, K. ^{[12
]}

Matthews, H. ^{[13
]}

Mestre, T. ^{[14
]}

Morel, T. ^{[15
]}

Minchik, M. ^{[1
]}

Muller, M. L. T. M. ^{[1
]}

Schroeder, K. ^{[16
]}

Simuni, T. ^{[17
]}

Stebbins, G. T. ^{[18
]}

Yan, C. H. ^{[19
]}

Zeissler, M. L. ^{[20
]}

Stephenson, D. ^{[1
]}

机构：

[1] Crit Path Inst, Tucson, AZ USA

[2] Roche Prod Ltd, Welwyn Garden City, Herts, England

[3] Coeruleus Clin Sci LLC, Woodbridge, CT USA

[4] US FDA, Off Neurosci, Silver Spring, MD USA

[5] Denali Therapeut, San Francisco, CA USA

[6] Takeda, Cambridge, MA USA

[7] Biogen, Cambridge, MA USA

[8] Parkinsons UK, London, England

[9] GlaxoSmithKline, Collegeville, PA USA

[10] Michael J Fox Fdn, New York, NY USA

[11] Merck & Co Inc, Kenilworth, NJ USA

[12] Inst Neurodegenerat Disorders, New Haven, CT USA

[13] Cure Parkinsons, London, England

[14] Univ Ottawa, Ottawa, ON, Canada

[15] UCB Pharmaceut, Brussels, Belgium

[16] Parkinsons Fdn, Miami, FL USA

[17] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[18] Rush Univ, Chicago, IL 60612 USA

[19] AbbVie Inc, Chicago, IL USA

[20] Univ Plymouth, Plymouth, Devon, England

来源：

MOVEMENT DISORDERS | 2022年 / 37卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S32 / S33

页数：2

共 50 条

[1] Optimizing patient-centric clinical outcome assessments for use in Parkinson's disease clinical trials: Critical Path for Parkinson's multistakeholder initiative
Speck, R.
Trundell, D.
Cedarbaum, J.
Campbell, M.
Chin, P.
Crawford, S.
Dam, T.
Dexter, D.
Goldfine, A.
Klapper, K.
Kopil, C.
Lee, S.
Marek, K.
Matthews, H.
Mestre, T.
Morel, T.
Minchik, M.
Mueller, M.
Schroeder, K.
Simuni, T.
Stebbins, G.
Yan, C.
Zeissler, M. L.
Stephenson, D.
[J]. MOVEMENT DISORDERS, 2022, 37 : S355 - S355
[2] The Linked Clinical Trials initiative (LCT) for Parkinson's disease
Brundin, Patrik
Wyse, Richard K.
[J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2019, 49 (03) : 307 - 315
[3] Patient Diaries As a Clinical Endpoint in Parkinson's Disease Clinical Trials
Papapetropoulos, Spyridon
[J]. CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (05) : 380 - 387
[4] Patterns of outcome measurement in Parkinson's disease clinical trials
Mitchell, SL
Harper, DW
Lau, A
Bhalla, R
[J]. NEUROEPIDEMIOLOGY, 2000, 19 (02) : 100 - 108
[5] Patient-Centric Care for Parkinson's Disease: From Hospital to the Community
Aye, Yin Minn
Liew, Sylvia
Neo, Shermyn Xiumin
Li, Wei
Ng, Hwee-Lan
Chua, Shu-ling
Zhou, Wen-Tao
Au, Wing-Lok
Tan, Eng-King
Tay, Kay-Yaw
Tan, Louis Chew-Seng
Xu, Zheyu
[J]. FRONTIERS IN NEUROLOGY, 2020, 11
[6] A patient-centric disease framework for Parkinson's disease levodopa induced dyskinesia
Shields, A. L.
Mallya, U. G.
Lane, R. M.
Thomas, S. K.
[J]. MOVEMENT DISORDERS, 2009, 24 : S68 - S68
[7] STUDY DESIGN CONSIDERATIONS FOR DIGITAL ASSESSMENTS IN PARKINSON'S DISEASE CLINICAL TRIALS
Lavine, J.
Scotina, A.
Izmailova, E.
Omberg, L.
[J]. VALUE IN HEALTH, 2024, 27 (06) : S287 - S287
[8] Critical Path for Parkinson's: Catalyzing Innovation for Parkinson's Clinical Trials through Data Sharing and Regulatory Science
Stephenson, Diane
Akalu, Mussie
Alexander, Robert
Bloem, Bastiaan
Boroojerdi, Babak
Bravi, Daniele
Burn, David
Cedarbaum, Jesse
Conrado, Daniela
Dorsey, E. Ray
Facheris, Maurizio
Fischer, Tanya
Frasier, Mark
Gallagher, Jill
Gordon, Mark
Graff, Ole
Grosset, Donald
Sheikh, Zulfiqar Haider
Hill, Derek
Ho, Carole
Hu, Michele
Hynds, Renee
Kieburtz, Karl
Lawson, Rachael
Macha, Sreeraj
Manolis, Efthymios
Marek, Kenneth
Matthews, Dawn
Nicholas, Timothy
Podskalny, Gerald
Post, Anke
Romero, Klaus
Russell, David
Seibyl, John
Stafford, Bob
Stebbins, Glenn
Tome, Maria
Venuto, Charles
Williams-Gray, Caroline
Yarnall, Alison
Dexter, David
[J]. NEUROLOGY, 2019, 92 (15)
[9] GDNF clinical trials for Parkinson's disease: a critical human dimension
Gash, Don Marshall
Gerhardt, Greg A.
Bradley, Luke H.
Wagner, Renee
Slevin, John T.
[J]. CELL AND TISSUE RESEARCH, 2020, 382 (01) : 65 - 70
[10] GDNF clinical trials for Parkinson’s disease: a critical human dimension
Don Marshall Gash
Greg A. Gerhardt
Luke H. Bradley
Renee Wagner
John T. Slevin
[J]. Cell and Tissue Research, 2020, 382 : 65 - 70

← 1 2 3 4 5 →